Bryce Vissel does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...

People affected by Huntington’s disease could at last benefit from the first treatment to slow the fatal neurodegenerative condition. Scientists from University College London (UCL) found patients ...

The Trump administration is touting an old generic drug as a new treatment for autism despite limited evidence, sparking unease among doctors and scientists who say the medication needs to be studied ...

Some practitioners provided ordinary lenses instead of special myopia control spectacles for children, potentially causing long-term harm. The Optometrists and Opticians Board issued a warning, ...

A gene therapy injected into patients’ brains slowed progression of the disease by 75 percent, preliminary findings reported. By Dana G. Smith Preliminary results from a small clinical trial to treat ...

Nick Benz-Bushling never imagined that managing his son’s mental health care would turn into a real-life horror story. After years of struggles, 16-year-old Johnathan attempted suicide in February.

Days after federal immigration agents detained Cary Lopez Alvarado, a 23-year-old Los Angeles native and U.S. citizen, she gave birth to a baby girl. Lopez Alvarado and her now 3-month-old child are ...

The president also blamed the painkiller Tylenol for autism, but the evidence doesn’t stack up at all. MIT Technology Review Explains: Let our writers untangle the complex, messy world of technology ...

A gamer seeking financial support for cancer treatment lost $32,000 after downloading from Steam a verified game named BlockBlasters that drained his cryptocurrency wallet. BlockBlasters is a 2D ...

President Donald Trump and his top health aides plan to link a common over-the-counter pain medication to autism and name another drug as a possible treatment for the brain development condition.

September 23 - On Monday, the U.S. Food and Drug Administration published a notice to the Federal Register ahead of a speech by President Donald Trump, approving a version of leucovorin made by ...